Micropos Medical is a Swedish company developing technology for enhanced radiotherapy cancer treatment. Their Raypilot® System offers accuracy through real-time tumor tracking in prostate cancer radiation treatment.
The 2024 Pace-B study showed that SBRT with five sessions is as effective as traditional treatments involving 20–40 sessions. In spring 2025, the Edinburgh Cancer Centre began treating prostate cancer patients within the Precision Study framework.
Professor Duncan McLaren, leading the study, states, "The goal of the Precision Study is to ensure that treatment with three radiation doses does not lead to greater side effects than those observed in the Pace-B study. I am confident that we can demonstrate effective cancer treatment with less side effects."
The treatments in the study are carried out using the Raypilot System, which enables real-time monitoring of organ movement, allowing urethra-sparing techniques and tighter radiation margins—factors that both improve targeting accuracy and reduce the risk of side effects.
Find out more here: The PACE-B Study and The PRECISION Study with Prof. Duncan McLaren
https://vimeo.com/1030748341
Emerging Trends in Radiotherapy in the UK and Scotland with Joanne Mitchell
https://vimeo.com/1044606667
FURTHER INFORMATION:
